Santhera Pharmaceuticals Holding AG (SPHDF)
18.30
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Santhera Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| BeOne Medicines Ltd. | 593.46M |
| AC Immune SA | 13.25M |
| CRISPR Therapeutics AG | 64.95M |
| Idorsia Ltd. | 31.45M |